View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
July 30, 2021updated 22 Mar 2022 6:51am

Covid-19 has accelerated the point-of-care testing market

The pandemic has had a particular impact on the point-of-care testing market, as companies aim to provide rapid and reliable methods for virus detection.

By GlobalData Healthcare

Point-of-care testing (POCT) is performed at the time and place of patient care. Types of POCT include blood glucose testing, rapid cardiac marker testing and infectious disease testing. POC testing devices have enhanced the diagnostic capacity for several severe diseases and disorders, with the technology’s biggest selling point being its drastic reduction of turnaround time.

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

Numerous factors are stimulating the demand for POC testing. These include the increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home-based POC devices, and technological advancements in molecular testing.

The Covid-19 pandemic in particular has accelerated the POC diagnostics market, with companies focused on developing these devices to provide a rapid and reliable method for virus detection. The gold standard in Covid-19 diagnostic testing is reverse transcription-polymerase chain reaction (RT-PCR) due to its high accuracy, ease of access and high throughput. Standard RT-PCR approaches, however, rely heavily on expensive equipment, well-trained staff and equipped laboratories. In addition, sample examination using this method usually takes between four and six hours, excluding the shipping time to laboratories, which increases the total turnaround time with a higher risk of cross-contamination.

POCT devices hit the market a few months after the first Covid-19 RT-PCR tests were deployed in order to address these issues. While throughput is lower, Covid-19 POC diagnostics, such as the Abbott ID Now, which utilises isothermal nucleic acid amplification, can deliver results in 15 minutes or less, allowing for real-time diagnosis. As new Covid-19 cases subside and high-throughput testing is not as urgent, Covid-19 POC diagnostics become a more attractive test due to the fast delivery time of results. According to GlobalData’s Marketed Products database, there are more than 500 Covid-19 POC diagnostics currently on the market.

Opportunities to implement successful POCT facilities have been expanding throughout the years as the technology has progressively improved. Due to the pandemic, the demand for these devices has increased and manufacturing companies are racing to make the next-generation POC platforms faster, easier and more reliable. POC diagnostics are, therefore, well-positioned to challenge traditional centralised laboratory methods.

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU